Leaders from across the region will meet to discuss the advancements in lab technology and the overarching industry, which has seen numerous developments over the past couple of years. With the conference setting its eyes on the evolution of the lab it will address 9 important and varying themes that encompass the breadth of this ever-growing field in Basel, May 27-28...
London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community...
Shimadzu Corporation, a pioneer in scientific instrumentation and technology, is proud to announce the celebration of its 150th anniversary. Founded in Kyoto on March 31, 1875, Shimadzu has been at the forefront of innovation and excellence in science and technology for over a century and a half. To commemorate this significant milestone, Shimadzu Corporation has launched a special website today, inviting everyone to join in the celebration...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases...
Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, have announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, AAVs, and other proteins directly from crude samples in as little as one minute, providing critical data on the spot, enhancing efficiency and accuracy in life science research and bioprocessing...
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors. Through the collaboration, biotech startups based at Pioneer sites across the UK and Ireland, including its new landmark life sciences location at Victoria House in London in partnership with Oxford Properties, will receive access to training, events, technical support, bespoke equipment, and consumables from Thermo Fisher...
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Azenta, Inc. has announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome that underpin many rare diseases, hindering accurate diagnoses and targeted treatments...
AchemAsia is back: from 14 to 16 October 2025, the trade show in Shanghai will once again present itself as the leading platform for the Chinese process industry as well as the chemical and pharmaceutical sectors. As the ‘International Expo and Innovation Forum for Sustainable Chemical Production’, the focus will be on innovative technologies for a climate-neutral future, including process technology, pharmaceutical technology and digitalisation...
Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland. Local representative Gerald Hurley, CEO of Waterford Chamber of Commerce, joined the Astoriom’s team for the company’s expansion into a new purpose built cryo suite, marking the significant milestone for the local community and Ireland’s growing life science sector...
Tracamyl has announced the acquisition of the Hektros brand formerly owned by Tratter Engineering. Hektros is the laboratory products entity of the plastic injection molding manufacturer Tratter Engineering. Tratter Engineering has a long-standing history in the automotive sector, being an important supplier of complex molded plastic parts for various car brands. Hektros develops and manufactures numerous devices and disposables for laboratory use in a broad range of chemical, biotechnological and medical-pharmaceutical fields....
Indica Labs, the global leader in AI-powered digital pathology, announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university based pathology institute in Switzerland, has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc. (AWS). The Institute selected Indica Labs for its ability to provide dependable, pathologist-centered software and AI in a powerful and highly flexible platform.
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI...
Researchers have developed a new multiple organ-on-chip system to help study how neurotoxins move from the gut to the brain. The model system simulated how a neurotoxin in the gut can trigger the brain cell death seen in Parkinson’s disease, in a proof-of-concept study from the Quadram Institute, University of Hull, University of Essex and at the UK Health Security Agency (UKHSA).
UK-based Concept Life Sciences (Concept) and Accelero Biostructures (Accelero) in the US have formed an industry-leading partnership which will help pharma businesses worldwide speed up drug development by up to tenfold. The collaboration accelerates the timeline for progressing from drug discovery to clinical trials through the integration of Accelero’s specialised X-ray crystallography and structural biology platforms...
Eppendorf SE, a leading life science company, and DataHow AG, a pioneer in advanced data analytics and AI-driven prediction software, are excited to announce a strategic collaboration aimed at transforming bioprocess development. This partnership will integrate DataHow's innovative AI-enabled analytics solution, DataHowLab, with Eppendorf's cloud-based monitoring and analytics platform, BioNsight® cloud, providing scientists with unparalleled insight and analytics capabilities....
Every year, INTEGRA makes a donation to a worthy cause, and at the start of 2024, the company partnered with CleanHub to help fund its plastic collection projects in developing countries. Over 2 billion people in coastal regions worldwide don't have access to proper waste management, meaning that discarded plastic often makes its way into the oceans, with the equivalent of one garbage truck full entering the sea every minute...
Titian Software (“Titian”), a market leader in life sciences sample management software, has announced that Griffith University’s Compounds Australia, Australia’s only dedicated compound management facility, has selected Titian’s Mosaic Sample Management platform (“Mosaic”) to manage their extensive compound collection and support future growth. Mosaic will enable optimisation of workflow efficiencies at Compounds Australia, underpinning the facility’s strategic growth to meet the needs of a growing drug discovery sector. ..
Leaders from across the region will meet to discuss the advancements in lab technology and the overarching industry, which has seen numerous developments over the past couple of years. With the conference setting its eyes on the evolution of the lab it will address 9 important and varying themes that encompass the breadth of this ever-growing field in Basel, May 27-28...
London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community...
Shimadzu Corporation, a pioneer in scientific instrumentation and technology, is proud to announce the celebration of its 150th anniversary. Founded in Kyoto on March 31, 1875, Shimadzu has been at the forefront of innovation and excellence in science and technology for over a century and a half. To commemorate this significant milestone, Shimadzu Corporation has launched a special website today, inviting everyone to join in the celebration...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases...
Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, have announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, AAVs, and other proteins directly from crude samples in as little as one minute, providing critical data on the spot, enhancing efficiency and accuracy in life science research and bioprocessing...
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors. Through the collaboration, biotech startups based at Pioneer sites across the UK and Ireland, including its new landmark life sciences location at Victoria House in London in partnership with Oxford Properties, will receive access to training, events, technical support, bespoke equipment, and consumables from Thermo Fisher...
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Azenta, Inc. has announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome that underpin many rare diseases, hindering accurate diagnoses and targeted treatments...
AchemAsia is back: from 14 to 16 October 2025, the trade show in Shanghai will once again present itself as the leading platform for the Chinese process industry as well as the chemical and pharmaceutical sectors. As the ‘International Expo and Innovation Forum for Sustainable Chemical Production’, the focus will be on innovative technologies for a climate-neutral future, including process technology, pharmaceutical technology and digitalisation...
Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland. Local representative Gerald Hurley, CEO of Waterford Chamber of Commerce, joined the Astoriom’s team for the company’s expansion into a new purpose built cryo suite, marking the significant milestone for the local community and Ireland’s growing life science sector...
Tracamyl has announced the acquisition of the Hektros brand formerly owned by Tratter Engineering. Hektros is the laboratory products entity of the plastic injection molding manufacturer Tratter Engineering. Tratter Engineering has a long-standing history in the automotive sector, being an important supplier of complex molded plastic parts for various car brands. Hektros develops and manufactures numerous devices and disposables for laboratory use in a broad range of chemical, biotechnological and medical-pharmaceutical fields....
Indica Labs, the global leader in AI-powered digital pathology, announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university based pathology institute in Switzerland, has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc. (AWS). The Institute selected Indica Labs for its ability to provide dependable, pathologist-centered software and AI in a powerful and highly flexible platform.
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI...
Researchers have developed a new multiple organ-on-chip system to help study how neurotoxins move from the gut to the brain. The model system simulated how a neurotoxin in the gut can trigger the brain cell death seen in Parkinson’s disease, in a proof-of-concept study from the Quadram Institute, University of Hull, University of Essex and at the UK Health Security Agency (UKHSA).
UK-based Concept Life Sciences (Concept) and Accelero Biostructures (Accelero) in the US have formed an industry-leading partnership which will help pharma businesses worldwide speed up drug development by up to tenfold. The collaboration accelerates the timeline for progressing from drug discovery to clinical trials through the integration of Accelero’s specialised X-ray crystallography and structural biology platforms...
Eppendorf SE, a leading life science company, and DataHow AG, a pioneer in advanced data analytics and AI-driven prediction software, are excited to announce a strategic collaboration aimed at transforming bioprocess development. This partnership will integrate DataHow's innovative AI-enabled analytics solution, DataHowLab, with Eppendorf's cloud-based monitoring and analytics platform, BioNsight® cloud, providing scientists with unparalleled insight and analytics capabilities....
Every year, INTEGRA makes a donation to a worthy cause, and at the start of 2024, the company partnered with CleanHub to help fund its plastic collection projects in developing countries. Over 2 billion people in coastal regions worldwide don't have access to proper waste management, meaning that discarded plastic often makes its way into the oceans, with the equivalent of one garbage truck full entering the sea every minute...
Titian Software (“Titian”), a market leader in life sciences sample management software, has announced that Griffith University’s Compounds Australia, Australia’s only dedicated compound management facility, has selected Titian’s Mosaic Sample Management platform (“Mosaic”) to manage their extensive compound collection and support future growth. Mosaic will enable optimisation of workflow efficiencies at Compounds Australia, underpinning the facility’s strategic growth to meet the needs of a growing drug discovery sector. ..